Recent research has also demonstrated the tumor-specific expression of CLPTM1L and its involvement in apoptosis resistance, particularly in lung and pancreatic cancers, where it enhances the expression of Bcl-xl, an anti-apoptotic protein [14, 15]. This evidence concerns the gene CLPTM1L and neoplasm.